Neutropenic sepsis Haematological Disorders
Conditions
Interventions
Neutrocheck is a single-use, portable device that accurately detects neutrophil and CRP levels using a blood finger-prick. The device uses lateral flow technology, with innovative housing enabling the
Sponsors
Cambridge University Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over 2. At risk of neutropenia or neutropenic sepsis
Exclusion criteria
Exclusion criteria: 1. Evidence of end-organ dysfunction or too unwell to use the Neutrocheck device (e.g systolic blood pressure < 90mmHG) 2. Known HIV or an active Hep B or Hep C infection 3. Bleeding disorder in which a finger prick test is contraindicated 4. Acute Myeloid Leukaemia 5. Significant visual impairment or blindness 6. Participants with significant manual dexterity issues that would prevent them from completing the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C-reactive protein and Neutrophils are measured by inserting a drop of the patients blood into the Neutrocheck device and then comparing the intensity of the assay line to a visual score card. An app on a phone is also used to take a photo of the assay to produce an automated score. These are both done on the fist patient visit. There are no subsequent visits. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom
Contacts
Public ContactGlenn Harden
Outcome results
None listed